The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
ARK Genomic Revolution ETF ARKG
Morningstar’s Analysis ARKG
Will ARKG outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Twist Bioscience Corp | 8.70 | 131.8 Mil | Healthcare |
CRISPR Therapeutics AG | 6.65 | 100.7 Mil | Healthcare |
Recursion Pharmaceuticals Inc Class A | 6.15 | 93.1 Mil | Healthcare |
CareDx Inc | 5.72 | 86.7 Mil | Healthcare |
Intellia Therapeutics Inc | 4.28 | 64.8 Mil | Healthcare |
Schrodinger Inc Ordinary Shares | 3.89 | 58.9 Mil | Healthcare |
Ionis Pharmaceuticals Inc | 3.62 | 54.9 Mil | Healthcare |
Beam Therapeutics Inc | 3.42 | 51.8 Mil | Healthcare |
Arcturus Therapeutics Holdings Inc | 3.38 | 51.1 Mil | Healthcare |
Moderna Inc | 3.33 | 50.4 Mil | Healthcare |